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Abstract
Background: The calcium activated protein phosphatase 2B, also known as calcineurin, has been
implicated as a cell signaling molecule involved with transduction of physiological signals (free
cytosolic Ca2+) into molecular signals that influence the expression of phenotype-specific genes in
skeletal muscle. In the present study we address the role of calcineurin in mediating adaptations in
myosin heavy chain (MHC) isoform expression and muscle mass using 3-month old wild-type (WT)
and transgenic mice displaying high-level expression of a constitutively active form of calcineurin
(MCK-CN* mice).
Results: Slow muscles, e.g., soleus, were significantly larger (by ~24%), whereas fast muscles, e.g.,
medial gastrocnemius (MG) and tibialis anterior were significantly smaller (by ~26 and ~16%,
respectively) in MCK-CN* mice compared to WT. The masses of mixed phenotype muscles, such
as the plantaris and the extensor digitorum longus, were not significantly changed from WT. The
soleus, plantaris, MG and diaphragm displayed shifts toward slower MHC isoforms, e.g., soleus
from WT mice contained ~52% MHC-I, ~39% MHC-IIa, and ~9% MHC-IIx, whereas MCK-CN*
mice had ~67% MHC-I, ~26% MHC-IIa, and ~7% MHC-IIx. The specific isoforms that were either
up or down-regulated were muscle-specific. For instance, the proportion of MHC-IIa was
decreased in the soleus and diaphragm, but increased in the plantaris and MG of MCK-CN* mice.
Also, the proportion of MHC-IIx was unchanged in the soleus, decreased in the diaphragm and
increased in the plantaris and MG of MCK-CN* relative to WT mice. Fast to slow shifts in fiber
type proportions were evident for the plantaris, but not the soleus. Fast, but not slow, plantaris
fibers of MCK-CN* mice had higher oxidative and lower glycolytic properties than WT.
Conclusion: These data suggest that calcineurin activation can influence muscle phenotype and
that the specific influence of calcineurin activation on the phenotypic and mass characteristics of a
muscle is dependent upon the original phenotypic state of the muscle.
Published: 28 July 2004
BMC Cell Biology 2004, 5:28 doi:10.1186/1471-2121-5-28
Received: 10 May 2004
Accepted: 28 July 2004
This article is available from: http://www.biomedcentral.com/1471-2121/5/28
© 2004 Talmadge et al; licensee BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution 
License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original 
work is properly cited.BMC Cell Biology 2004, 5:28 http://www.biomedcentral.com/1471-2121/5/28
Page 2 of 12
(page number not for citation purposes)
Background
Skeletal muscle adapts to neural and use-dependent sig-
nals by altering its mass and phenotypic properties,
including the proportion of slow (I) and fast (IIa, IIx, and
IIb) myosin heavy chain (MHC) isoforms [1,2]. Cal-
cineurin has been implicated as a regulatory molecule
involved in the transduction of contractile activity-based
signals to molecular signals involved in the regulation of
muscle growth and phenotypic gene expression in skeletal
muscle [3-14]. Calcineurin is a phosphatase (protein
phosphatase 2B) that is activated by calmodulin upon
binding Ca2+ and has been shown to play an important
role in the regulation of cytokine gene expression in lym-
phocytes [15,16]. Substrates for calcineurin include the
phosphorylated isoforms of a transcription factor known
as the nuclear factor of activated T cells (NFAT) [17].
Upon dephosphorylation, NFAT isoforms translocate into
the nucleus where they can bind to a conserved DNA
binding site known as the NFAT response element (NRE)
and alter transcription, leading to enhanced expression of
specific genes [15-17].
It has been proposed that in skeletal muscle nuclear NFAT
can activate the expression of slow muscle phenotypic
genes [3-5,8,11,14]. In addition, MEF2 and NFAT appear
to act synergistically in turning on slow muscle fiber spe-
cific genes [18]. Thus, increased muscle contractile activity
and the resulting sustained elevations in cytosolic Ca2+
could potentially result in altered phenotype-specific gene
expression via calcineurin [4]. To date, however, no stud-
ies have reported the influence of chronically elevated cal-
cineurin activity on the MHC isoform composition and
fiber cross-sectional areas (CSAs) of limb and respiratory
skeletal muscles. Therefore, in the present study, trans-
genic mice containing a highly expressed transgene con-
sisting of a constitutively active form of calcineurin (CN*)
driven by the muscle creatine kinase (MCK) enhancer
were used to assess the influence of chronic calcineurin
activation on MHC isoform protein and muscle mass and
fiber cross-sectional area (CSA). Previous studies using the
same line of transgenic mice demonstrated that cal-
cineurin activation elevates the expression of some slow
phenotypic genes [11], the percentage of EDL fibers with
MHC-IIa [19], and proteins related to insulin-stimulated
glucose uptake [20].
Results
The MCK-CN* transgenic mice expressed the transgene in
all muscles tested as shown in Figure 1. As expected, due
to transgene expression being driven by a fast muscle-spe-
cific enhancer (MCK enhancer), the fast MG muscle dis-
played the highest level of expression. The soleus (a mixed
fast and slow muscle in mice), diaphragm and plantaris
showed relatively similar levels of transgene expression.
As shown in Figure 2, the muscles from MCK-CN* mice
showed significant shifts towards slower MHC isoforms
compared to WT. However, the specific isoforms that were
either up- or down-regulated were muscle specific. For
instance, the soleus of MCK-CN* mice showed an eleva-
tion in MHC-I at the expense of MHC-IIa. The MG showed
a reduction in MHC-IIb, the fastest of the MHC isoforms
expressed in mice, and elevations in MHCs-I, -IIa, and -IIx.
The diaphragm showed an elevation in MHC-I and reduc-
tions in MHCs-IIa and -IIx. The diaphragm of the MCK-
CN* mice also showed a complete absence of MHC-IIb,
which was present in small proportions in WT mice. The
plantaris of MCK-CN* mice showed similar directional
adaptations in MHC isoforms as did the MG, i.e., higher
proportions of MHCs-I, -IIa, and -IIx, and reduced MHC-
IIb relative to WT mice. Thus, in MCK-CN* mice, MHC-I
was consistently elevated and MHC-IIb reduced (if it was
present in the WT muscle). In contrast, MHC-IIa was
increased in the MG and plantaris, but decreased in the
soleus and diaphragm of MCK-CN* mice. Also, MHC-IIx
was increased in the MG and plantaris, decreased in the
diaphragm, and unchanged in the soleus of MCK-CN*
mice relative to WT.
The plantaris muscle of MCK-CN* mice showed a signifi-
cant shift in fiber type proportions from fast to slow as
measured by the proportions of fast and slow isoforms of
MHC, sarco(endo)plasmic reticulum Ca2+-ATPase
(SERCA), and troponin I (Figure 3). Plantaris fibers that
stained positively for the slow isoform of one protein
stained positively for the slow isoforms of the other pro-
teins and likewise for fast protein isoforms. In contrast,
immunohistochemical techniques did not detect signifi-
cant differences in the proportions of fibers containing
specific MHC isoforms in the soleus of MCK-CN* mice
(Figure 4). However, there was a non-statistically signifi-
cant tendency for increased proportions of fibers with
slower MHC isoforms.
To ascertain if other phenotypic properties of muscle fib-
ers were influenced by calcineurin activation, plantaris
fibers of MCK-CN* and WT mice were analyzed for
marker enzymes of oxidative (succinate dehydrogenase,
SDH) and glycolytic (α-glycerophosphate dehydrogenase,
GPD) capacity. Fast plantaris fibers of MCK-CN* mice
showed a significant increase in SDH staining intensity,
indicative of elevated mitochondrial content, and a
decrease in glycolytic staining intensity, indicative of
reduced glycolytic capacity (Figure 5). In contrast, slow
plantaris fibers of MCK-CN* mice were not different from
WT (Figure 5).
As shown in Table 1, the mass of a characteristically slow
muscle, i.e., the soleus, was greater; whereas, the mass of
characteristically fast muscles, i.e., the MG and tibialisBMC Cell Biology 2004, 5:28 http://www.biomedcentral.com/1471-2121/5/28
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A) SYBR® Green I stained agarose gel of PCR products following RT-PCR for the MCK-CN* mRNA product Figure 1
A) SYBR® Green I stained agarose gel of PCR products following RT-PCR for the MCK-CN* mRNA product. No specific 
product (~900 bp, arrow) is observed in the DNase-treated RNA samples (first 4 lanes) of either wild-type (WT) or MCK-
CN* transgenic (CN*) mouse gastrocnemius. Therefore, there is no contaminating genomic DNA in the RNA samples used 
for RT-PCR. As expected, RT-PCR of the cDNA (second four lanes) reveals that expression of the transgene is only observed 
in the MCK-CN* mice. A positive (+) control of tail DNA from an MCK-CN* mouse is shown on the right. B) Western blot of 
CN* and WT mouse soleus (SOL), diaphragm (DIA), plantaris (PLANT) and gastrocnemius (GAST) muscles for calcineurin. 
The polyclonal MAb recognized both the endogenous (CN, ~60 kDa) and constitutively active (CN*, ~45 kDa) forms. As 
expected, muscle from WT muscles did not contain the CN* protein. C) Relative semi-quantitative analysis of CN* mRNA (via 
RT-PCR) and protein (western blotting) in muscles of MCK-CN* mice. All values were normalized to the same soleus muscle 
(n = 3 – 6 per group). The asterisk (*) denotes significantly different (p ≤ 0.05) from other muscles.
A     DNase-treated RNA                             cDNA 
┌───────────┐             ┌───────────┐
 WT   WT    CN*  CN*           WT   WT    CN*  CN*    +
B                    SOL                 DIA        PLANT         GAST
        ┌─────┐      ┌────┐   ┌────┐     ┌────┐
                  CN*     WT      CN*   WT   CN*   WT     CN*   WT 
C 
   CN* 
CN* 
CN BMC Cell Biology 2004, 5:28 http://www.biomedcentral.com/1471-2121/5/28
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anterior were lower in MCK-CN* vs. WT mice. The masses
of muscles that characteristically display a more interme-
diate phenotype, with relatively high proportions of fast
oxidative (i.e., IIa and IIx) fibers, i.e., the plantaris and the
extensor digitorum longus, were unchanged.
As expected, based on the overall differences in muscle
mass between MCK-CN* and WT mice, the soleus con-
tained fibers with CSAs greater than WT, whereas the MG
contained fibers with CSAs smaller than WT (Figure 6A).
The plantaris, which showed no change in mass, also
showed no change in fiber CSA (Figure 6B). In the soleus,
both slow and fast fibers were larger (Figure 6C). How-
ever, slow fibers were increased in CSA by 49% and fast
fibers by only 22%. This resulted in a ~20% increase in the
proportion of the muscle CSA occupied by slow fibers in
Adult myosin heavy chain (MHC) isoform proportions of the soleus (A), medial gastrocnemius (B), diaphragm (C), and plantaris  (D) muscles of wild-type (dark bars) and MCK-CN* transgenic (gray bars) mice as determined by SDS-PAGE of whole muscle  extracts Figure 2
Adult myosin heavy chain (MHC) isoform proportions of the soleus (A), medial gastrocnemius (B), diaphragm (C), and plantaris 
(D) muscles of wild-type (dark bars) and MCK-CN* transgenic (gray bars) mice as determined by SDS-PAGE of whole muscle 
extracts. The * denotes significantly different from wild-type at p ≤ 0.05. Note the elevated proportions of slower MHC iso-
forms in the transgenic mice compared to wild-type.BMC Cell Biology 2004, 5:28 http://www.biomedcentral.com/1471-2121/5/28
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MCK-CN* mice (Figure 6D). Thus, the changes in overall
phenotype of the soleus can be partially accounted for by
changes in the size of specific types of fibers.
Discussion
Elevated calcineurin activity altered the phenotypic pro-
file and mass of both fast and slow muscles and muscle
fibers. The phenotypic changes were indicated by the gen-
eral fast to slow adaptation in MHC isoform expression in
MCK-CN* versus WT mice. The changes in phenotype
were apparently not restricted to MHC isoforms since the
plantaris of MCK-CN* mice had higher proportions of
fibers that stained positive for the slow isoforms of MHC,
SERCA and troponin I, suggesting a coordinated increase
in the expression of slow phenotypic proteins upon cal-
cineurin activation. Fast plantaris fibers also had elevated
oxidative and reduced glycolytic profiles, suggesting that
calcineurin activation influenced the metabolic profile of
fibers promoting a more oxidative phenotype. These data
suggest that fibers that did not show adaptations in MHC,
SERCA or troponin I isoforms and remained fast were still
influenced by calcineurin activation to acquire an oxida-
tive phenotype. These changes are consistent with the pro-
posed role of calcineurin as a sensor of contractile activity
and transducer of contractile signals into molecular sig-
nals that induce the expression of a slow oxidative pheno-
type [4].
The overall changes in MHC isoform composition for
some muscles, such as the soleus, were apparently aided
by fiber type-specific changes in the CSA of the fibers, such
that type I fibers were increased and type II fibers
decreased (or increased only slightly in the soleus) in CSA
as a result of elevated calcineurin activity. These data are
consistent with the hypothesis that elevated calcineurin
activity induces increased expression of slow muscle phe-
notypic genes resulting in elevated mass of slow muscles
and muscle fibers. In addition, fibers from fast muscles
may attain a smaller CSA in MCK-CN* mice relative to WT
as a result of the change in phenotype from a fast
glycolytic type of fiber (typically the largest fibers)
towards a slow or fast oxidative type of fiber (typically the
smallest fibers), see Rivero et al. [21,22].
Although the general adaptations in phenotype were in
the direction of faster to slower isoforms, the actual tran-
sitions in MHC isoform content were muscle-specific.
This is reminiscent of the muscle-specific influence of
Proportions of plantaris fibers staining positively for slow and  fast isoforms of MHC, sarco(endo)plasmic reticulum Ca2+  ATPase (SERCA), and troponin I (Tn I) in wild-type and  MCK-CN* transgenic mice Figure 3
Proportions of plantaris fibers staining positively for slow and 
fast isoforms of MHC, sarco(endo)plasmic reticulum Ca2+ 
ATPase (SERCA), and troponin I (Tn I) in wild-type and 
MCK-CN* transgenic mice. MHC-I, SERCA2, and TN I slow 
are the slow muscle isoforms and MHC-II, SERCA1 and Tn I 
fast are the fast muscle isoforms. The * denotes significantly 
different from wild-type at p ≤ 0.05. Note the elevated pro-
portions of fibers staining positively for the slow isoforms in 
the transgenic mice compared to wild-type. All fibers that 
stained positively for the slow MHC (MHC-I) were positive 
for the slow isoforms of SERCA and Tn I and all fibers that 
stained positively for the fast MHC (MHC-II) were positive 
for the fast isoforms of SERCA and Tn I.
Proportions of soleus fibers staining positively for specific  fast and slow MHC isoforms in wild-type and MCK* trans- genic mice Figure 4
Proportions of soleus fibers staining positively for specific 
fast and slow MHC isoforms in wild-type and MCK* trans-
genic mice. No fibers stained positively for MHC-IIb with 
mAb BF-F3, thus antibody RT-D9 which is specific for MHC-
IIx and MHC-IIb indicated the presence of MHC-IIx. No sig-
nificant differences in fiber proportions of the soleus were 
found between wild-type and MCK-CN* mice.BMC Cell Biology 2004, 5:28 http://www.biomedcentral.com/1471-2121/5/28
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Oxidative and glycolytic enzymatic profiles of individual plantaris fibers of wild-type and MCK-CN* transgenic mice Figure 5
Oxidative and glycolytic enzymatic profiles of individual plantaris fibers of wild-type and MCK-CN* transgenic mice. The * 
denotes significantly different from wild-type at p ≤ 0.05. A) The specific activity of succinate dehydrogenase (SDH, oxidative 
marker) was increased in fast (type II) plantaris fibers, but unchanged in slow (type I) fibers. The specific activity of α-glycero-
phosphate dehydrogenase (GPD, glycolytic marker) was significantly decreased in fast plantaris fibers, but not slow fibers. B) 
The integrated activity (see methods for explanation of integrated activity) of succinate dehydrogenase (SDH, oxidative 
marker) was increased in fast (type II) plantaris fibers, but unchanged in slow (type I) fibers. The integrated activity of α-glycer-
ophosphate dehydrogenase (GPD, glycolytic marker) was significantly decreased in fast plantaris fibers, but not slow fibers. C) 
The GPD/SDH ratio (glycolytic/oxidative ratio) was significantly decreased in fast fibers, but unchanged in slow fibers of the 
plantaris of MCK-CN* mice relative to wild-type.BMC Cell Biology 2004, 5:28 http://www.biomedcentral.com/1471-2121/5/28
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thyroid hormone treatment on muscle phenotype [23].
Of the muscles examined, the diaphragm of MCK-CN*
mice showed the greatest absolute elevation in MHC-I
content. Also, in the soleus and diaphragm of MCK-CN*
mice, MHC-I was up-regulated at the expense of MHC-IIa.
However, in the MG, MHCs-I, -IIa, and -IIx were up-regu-
lated at the expense of MHC-IIb. The mechanisms by
which some muscles (MG and plantaris) respond to cal-
cineurin activation by up-regulating MHC-IIa and IIx
whereas others (soleus and diaphragm) down-regulate
these MHCs is currently unknown. In vitro data suggest
that MHC-IIa is highly (100 fold) and MHC-IIx and -IIb
moderately (~5 – 10 fold) stimulated by calcineurin acti-
vation in mouse C2C12 cells [24]. Because the adaptations
were muscle-specific it is likely that additional mecha-
nisms must be invoked in the in vivo state to modulate the
ultimate response to calcineurin activation. Since the dia-
phragm showed the greatest response to calcineurin acti-
vation and the diaphragm is a chronically active muscle it
is tempting to speculate that the chronic motor activity of
this muscle results in an up-regulation of parallel signal-
ing pathways that may support a more pronounced cal-
cineurin activity-induced shift in fiber phenotype.
The observation that MHC-IIa and MHC-IIx were up-reg-
ulated in fast muscles and MHC-I was up-regulated in
slow muscles of MCK-CN* mice is in agreement with the
idea of a limited adaptive range for muscles of varying
phenotype. The limited adaptive range theory essentially
states that muscles from a slow developmental lineage
have the capacity to adapt in the range of I ↔ IIa ↔ IIx,
whereas muscles from a fast developmental lineage can
adapt in the range of IIa ↔ IIx ↔ IIb [25]. Thus, MG and
plantaris fibers may be restricted to express MHC-IIa as
the 'slowest' MHC isoform. In contrast, soleus and dia-
phragm fibers have the capacity to express MHC-I as the
slowest MHC. However, recent data demonstrate that the
suggested limited adaptive range for slow muscle is not
strict. For example, combined treatment of rats with thy-
roid hormone and hindlimb suspension results in sub-
stantial expression of MHC-IIb by the soleus [26].
Another potential explanation for the muscle-specific
response to chronic calcineurin activation is a possible
obligatory step-wise transition from MHC-IIb ↔ IIx ↔ IIa
↔ I [27]. Following this scheme a fast muscle fiber would
initially express MHC-IIx and then IIa as it transitioned
towards a slower phenotype. However, this is a temporal
scheme and the animals in this study were 3 months of
age, therefore, sufficient time was available for a complete
transition of fast muscles to MHC-I. In addition, previous
studies from our [28-31] and other [26,32] laboratories
have demonstrated that the obligatory step-wise transi-
tion scheme is not always followed. For instance, some rat
soleus fibers can transition from MHC-I to MHC-IIx with-
out apparent expression of MHC-IIa protein following
hindlimb suspension, spaceflight, or paralysis induced by
either spinal cord transection or spinal cord isolation [28-
31].
The molecular mechanisms involved in directing the mus-
cle-specific response are unknown, but could involve
parallel signaling pathways, perhaps involving CAMKi-
nase, MEF2, PGC-1, or altered histone acetylation at spe-
cific sites. It is also possible that variability in inherent
motor-neuron activity influences the expression of spe-
cific sets of parallel signaling pathways which in turn
allows for alteration of only specific sets of phenotypic
proteins in muscles of differing phenotype. Our data
showing that the diaphragm, a chronically active muscle,
Table 1: Body and absolute and relative muscle masses.
Wild-type (n = 6) MCK-CN* (n = 10)
Body Mass (g) 23.3 ± 0.9 20.7 ± 0.4*
Absolute Muscle Mass (mg)
Soleus 8.2 ± 0.6 10.2 ± 0.6*
MG 46.7 ± 1.8 34.5 ± 1.9*
PLT 16.8 ± 0.8 16.2 ± 0.7
TA 43.0 ± 1.2 36.0 ± 1.3*
EDL 8.3 ± 1.3 7.8 ± 0.5
Relative Muscle Mass (mg/g body mass)
Soleus 0.35 ± 0.02 0.48 ± 0.02*
MG 2.01 ± 0.04 1.66 ± 0.09*
PLT 0.72 ± 0.03 0.78 ± 0.04
TA 1.85 ± 0.04 1.74 ± 0.06
EDL 0.36 ± 0.05 0.38 ± 0.03
Abbreviations: MG, medial gastrocnemius; PLT, plantaris; TA, tibialis anterior; EDL, extensor digitorum longus. Values with asterisks are significantly 
different from wild-type at p ≤ 0.05.BMC Cell Biology 2004, 5:28 http://www.biomedcentral.com/1471-2121/5/28
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had the greatest absolute increase in MHC-I protein lends
support to this idea.
Ultimately, these data support the idea that calcineurin
activity plays a role in the regulation of muscle phenotype.
Since the expression level of the transgene in these mice
results in basal calcineurin activity levels that are ~10
times the activity in WT mice [33], and since the pheno-
typic adaptations were somewhat modest, this suggests
that parallel pathways likely need to be invoked to induce
a more complete fiber type shift. In addition, the activa-
tion of calcineurin did not completely supersede the
developmental-based phenotypic lineage. For instance, in
the MCK-CN* mice the soleus retained ~40% fast (type II)
fibers and the MG was predominantly composed of fast
MHC isoforms. However, it must be noted that the trans-
gene is active in the MCK-CN* mice during all stages of
development. Thus, negative feedback mechanisms that
may reduce the down-stream effectiveness of calcineurin
activation may be enhanced or invoked during the
development and maturation of the skeletal musculature.
It is also possible that parallel pathways must be invoked
with calcineurin to fully activate the slow muscle specific
phenotype, as suggested by Dunn et al., [7] and
Individual fiber cross sectional areas (CSAs) in muscles of wild-type and MCK-CN* mice Figure 6
Individual fiber cross sectional areas (CSAs) in muscles of wild-type and MCK-CN* mice. A) Mean fiber CSAs in soleus and 
medial gastrocnemius (MG) muscle regardless of fiber type. B) Mean fiber CSAs of slow (type I) and fast (type II) fibers of the 
plantaris muscle. C) Mean fiber CSAs of slow (type I) and fast (type II) fibers of the soleus muscle. D) The percent of the entire 
soleus muscle cross-section occupied by slow (type I) and fast (type II) fibers. The * denotes significantly different from wild-
type at p ≤ 0.05.BMC Cell Biology 2004, 5:28 http://www.biomedcentral.com/1471-2121/5/28
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demonstrated by Wu et al., [18]. Presence of the transgene
will only directly influence the basal calcineurin activity
and it is possible that higher sustained levels of cal-
cineurin activity, such as may occur with sustained con-
tractile activity-induced elevations in myoplasmic
calcium, would support a more complete fiber transfor-
mation. Since the Ca2+-calmodulin stimulation of cal-
cineurin can be as great as 100-fold [15], it is possible that
normal in vivo calcium-induced activation of endogenous
calcineurin would result in a much greater elevation in
calcineurin activity and a greater degree of fiber type
transformation.
Several studies have suggested that calcineurin activation
does not influence muscle mass [7,34-36] or phenotype
[37]. One of these studies, Dunn et al., [7], made use of a
similar transgenic mouse model as that used in this study.
However, the level of basal calcineurin activity in the mice
used by Dunn et al., [7] was reported to be several times
lower (~same as WT) than that reported for the mice used
in our study, ~10× greater than WT, i.e., transgenic mouse
line #1 from reference [33]. Thus, the lack of effect in
some of the previous studies may be related to the level of
transgene expression and the lower basal calcineurin
activity. It is interesting to note that the transgenic mice
used by Dunn et al. [7], also did not display differences in
fiber phenotype compared to WT. In contrast, other stud-
ies have demonstrated that calcineurin activation and or
the accumulation of nuclear NFAT may be involved in the
mediation of growth inducing factors, such as IGF-1
[10,13,38].
Curiously, our data suggest that chronic calcineurin acti-
vation results in elevated mass of slow muscle and
reduced mass of fast muscle. This suggests that the
changes in mass and fiber CSA may be secondary to the
changes in phenotype. The differential effect of chronic
calcineurin activation on slow vs. fast muscle mass may be
explained as follows. Elevated expression of slow pheno-
typic genes in a slow muscle could theoretically result in
an increased accretion of slow phenotypic proteins and
elevated size of slow fibers. Fast muscle fibers showed an
elevation in oxidative enzyme activity, i.e., transitioned
from a fast glycolytic (FG) to a fast oxidative glycolytic
(FOG) phenotype. Typically, FG fibers are larger than
FOG fibers in mammalian muscle. A strong inverse corre-
lation exists between oxidative capacity and fiber CSA
[39,40]. Thus, as fast fibers transitioned from FG towards
FOG in response to calcineurin activation, they would
achieve a smaller CSA.
Conclusions
Collectively, the data support the hypothesis that cal-
cineurin activation plays an important role in the modu-
lation of skeletal muscle phenotype. The responses to
calcineurin activation were muscle specific, suggesting
that inherent differences in signaling mechanisms within
distinct muscles likely modulate the response to cal-
cineurin activation. The observation that a 10-fold
increase in basal calcineurin activity results in alterations
in the expression of fast versus slow phenotypic proteins
and alterations in the metabolic capacities of fibers that
do not show a transition to slow fiber type isoforms sug-
gests that the activation of this pathway can modulate
multiple aspects of fiber phenotype. However, parallel
pathways likely need to be invoked to completely alter the
phenotype of all fibers in a muscle.
Methods
Animals
Breeding pairs of MCK-CN* transgenic mice were
obtained from the primary colony at the University of
Texas Southwestern Medical Center [11] and housed at
the Animal Care Facility at Virginia Polytechnic Institute
and State University. This specific line of transgenic mice
has been used previously to study the influence of cal-
cineurin activation on the expression of utrophin [19],
and insulin-sensitive glucose uptake [20]. Female B6C3F1
mice expressing a transgene consisting of 4800 bp of the
MCK enhancer, the coding sequence of the activated form
of calcineurin, which codes for amino acids 1 to 398 and
lacks the autoinhibitory and calmodulin binding
domains [41], and 620 bp of the human growth hormone
polyadenylation signal (MCK-CN* mice) were crossed
with the C57Bl6J strain. Transgenic offspring were identi-
fied by PCR amplification of tail DNA using primers spe-
cific for sequences within the calcineurin coding region
(5'-GAA CCA GCA GTT CCT GTG TGT ACA CG-3') and
the hGH polyadenylation signal (5'-CAC TCC AGC TTG
GTT CCC GAA TAG AC-3'). Since the transgenic mice were
generated in the B6C3F1 strain and were then crossed
with the C57Bl6J line, all comparisons were made to wild-
type (WT) littermate controls, which would share any
strain dependent variables with the MCK-CN* transgenic
mice. All animal procedures were approved by the Vir-
ginia Polytechnic Institute and State University and Cali-
fornia State Polytechnic University Institutional Animal
Care and Use Committees and conform to the American
Physiological Society's guiding principles for the care and
use of animals.
MCK-CN* (n = 10) and WT littermate controls (n = 6)
were sacrificed by pentobarbital injection at 3 months of
age. Animals from two independent litters were used. The
diaphragm, soleus, medial gastrocnemius (MG),
plantaris, tibialis anterior, and extensor digitorum longus
muscles were dissected free, trimmed of excess connective
tissue, and weighed (diaphragm weights were not
obtained). The muscles (except tibialis anterior and exten-
sor digitorum longus) were then rapidly frozen in meltingBMC Cell Biology 2004, 5:28 http://www.biomedcentral.com/1471-2121/5/28
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isopentane cooled with liquid nitrogen and stored at -
70°C.
Muscle RNA analyses
Total RNA was isolated from frozen muscle (soleus, MG,
plantaris, and diaphragm) samples using Trizol reagent
according to the manufacturer's instructions (Invitrogen
Corp., Carlsbad, CA, USA). The final RNA pellet was dis-
solved in nuclease-free water, treated with DNA-free™
(Ambion Inc, Austin, TX, USA) to remove potential con-
taminating genomic DNA, and then quantified by UV
(A260) light absorbance. All RNA samples had A260:A280
ratios of greater than 1.8. Two µg of the isolated RNA were
reverse transcribed to cDNA with Superscript II (Invitro-
gen Corp.) in a final volume of 20 µl. The same PCR prim-
ers used for genotyping were used to amplify the specific
cDNA fragment from transgenic mice expressing the
MCK-CN* transgene. The PCR reaction included: 1 µl of
cDNA, 1X Platinum Taq PCR buffer (Invitrogen Corp.),
1.5 mM MgCl2, 0.2 mM dNTPs, 1 µM each primer, and 1
unit Platinum Taq (Invitrogen Corp.) in a final volume of
25 µl. The PCR cycle conditions were 94°C for 4 min and
then 40 cycles of 94°C for 30 sec, 61°C for 30 sec, and
72°C for 30 sec, followed by a final step at 72°C for 5
min. The PCR products were separated on 1.5% agarose
gels, stained with SYBR® green I (Molecular Probes Inc.,
Eugene, OR, USA) and quantified using a ChemiImager
5500 (Alpha Innotech, San Leandro, CA, USA).
Muscle protein analyses
One MG, plantaris and soleus muscle from each animal
were serially sectioned perpendicular to the fiber axis
using a Microm cryostat, stained imuunohistochemically
for fast or slow myosin heavy chain (MHC) isoforms
using either anti-fast or anti-slow MHC monoclonal anti-
bodies (mAb, Novocastra Laboratories, Inc.) according to
Talmadge et al., [30]. Soleus tissue sections were also
analyzed for the presence of MHC-IIa, MHC-IIx and
MHC-IIb using mAbs specific for MHC-IIa (mAb SC-71),
MHCs-IIx & -IIb (mAb RT-D9) and MHC-IIb (mAb BF-
F3). Serial sections of the plantaris were also
immunohistochemically stained for the presence of fast
and slow isoforms of troponin I (Research Diagnostics
Inc.) and sarco(endo)plasmic reticulum Ca2+  ATPase
(SERCA, Novocastra Laboratories, Inc.) isoforms using
similar techniques. The sections treated for immunohisto-
chemistry were used to measure the cross-sectional area
(CSA) of fifty individual muscle fibers per muscle using a
calibrated microscopy-based image analysis system con-
sisting of a GMS-300 grayscale microscopy system (Scion,
Frederick, MD) and a Nikon Eclipse E400 microscope.
The MG, plantaris and soleus from the opposite limb and
the whole diaphragm (including costal and crural por-
tions) were subjected to high resolution SDS-PAGE for
analysis of myosin heavy chain isoforms as detailed in
Talmadge and Roy [42]. These muscles were also analyzed
for constitutively active and endogenous calcineurin pro-
tein levels by semi-quantitative western blotting as
described in detail previously by Spangenburg et al. [43].
The primary antibody used for western blotting was a rab-
bit anti-calcineurin Pan A polyclonal (AB1695) from
Chemicon International (Temecula, CA, USA) which rec-
ognized both the constitutively active (CN*) and endog-
enous forms of calcineurin. The western blot results
obtained using this primary antibody were verified (data
not shown) with other antibodies that showed similar
patterns of reactivity, including antibodies CN-A1 (Sigma
Chemical Co., St. Louis, Mo, USA), SC-9070 (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA), and AB1696
(Chemicon International).
Quantitative histochemistry of individual muscle fibers
Quantitative histochemical analyses of oxidative and gly-
colytic enzyme activities were measured on 50 plantaris
fibers per muscle that were immunohistochemically typed
for fast or slow MHC isoform content in serial sections.
According to Rivero et al., [21,22], succinate dehydroge-
nase (SDH; EC 1.3.5.1) was used as a marker for oxidative
capacity and α-glycerophosphate dehydrogenase (GPD)
was used as a marker for glycolytic capacity of individual
muscle fibers. Histochemical staining and image analysis
were performed as previously described in detail [21,22].
The specific enzymatic activity per unit fiber volume (i.e.,
enzyme concentration) is expressed as change in OD per
minute of reaction. The integrated enzymatic activities
(ISDH and IGPD) were calculated as the product of spe-
cific enzymatic activity (OD/min for a given fiber) and
CSA of that fiber which reflects the enzyme content per
fiber and is expressed as OD/min × microns2.
Statistical analyses
Student's t-tests were used for comparing mean data
between transgenic and WT mice at each age. Statistical
differences were significant at p ≤ 0.05.
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